VFA
NMTR

Valeo Financial Advisors’s 9 Meters Biopharma NMTR Stock Holding History

Valeo Financial Advisors’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,484
Closed -$45K – 618
2022
Q3 		$45K Buy
10,484
+577
+6% +$2.86K ﹤0.01% 480
2022
Q2 		$52K Hold
9,907
– – ﹤0.01% 474
2022
Q1 		$119K Hold
9,907
– – 0.01% 574
2021
Q4 		$194K Hold
9,907
– – 0.01% 522
2021
Q3 		$258K Hold
9,907
– – 0.01% 433
2021
Q2 		$218K Hold
9,907
– – 0.01% 430
2021
Q1 		$232K Buy
9,907
+7,745
+358% +$238K 0.01% 410
2020
Q4 		$37K Buy
+2,162
New +$36.1K ﹤0.01% 879

Other funds holding NMTR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
ODFS
O'Donnell Financial Services San Rafael, California $290M AUM 15.6% 1-Year Est. Return

Valeo Financial Advisors's NMTR Position: Q4 2022 in Review

Valeo Financial Advisors sold out of 9 Meters Biopharma (NMTR) in Q4 2022, closing a stake of 10,484 shares — an estimated $45K sold.

Valeo Financial Advisors first reported a position in NMTR in Q4 2020 and held it in 8 quarters. The position peaked at $258K in Q3 2021. 42 funds tracked by Wall St. Rank hold NMTR as of Q4 2022.

  • Valeo Financial Advisors reported no remaining 9 Meters Biopharma position as of Q4 2022 after selling out during the quarter.
  • Valeo Financial Advisors sold 10,484 9 Meters Biopharma shares in Q4 2022, an estimated $45K.
  • Valeo Financial Advisors first reported a position in 9 Meters Biopharma in Q4 2020 and held it in 8 quarters.
  • Valeo Financial Advisors's 9 Meters Biopharma position peaked at $258K in Q3 2021.
  • 42 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2022.

Based on Valeo Financial Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.